Streamline Health Financials
STRM Stock | USD 3.12 0.03 0.95% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.66 | 0.5616 |
|
| |||||
Current Ratio | 0.61 | 0.6458 |
|
|
The essential information of the day-to-day investment outlook for Streamline Health includes many different criteria found on its balance sheet. An individual investor should monitor Streamline Health's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Streamline Health.
Net Income |
|
Streamline | Select Account or Indicator |
Understanding current and past Streamline Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Streamline Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Streamline Health's assets may result in an increase in income on the income statement.
Streamline Health Stock Summary
Streamline Health competes with HealthStream, National Research, Forian, HealthEquity, and Health Catalyst. Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia. Streamline Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 134 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US86323X1063 |
CUSIP | 86323X106 862683109 516555109 |
Location | Georgia; U.S.A |
Business Address | 2400 Old Milton |
Sector | Health Care Technology |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.streamlinehealth.net |
Phone | 888 997 8732 |
Currency | USD - US Dollar |
Streamline Health Key Financial Ratios
Return On Equity | -0.8 | ||||
Profit Margin | (0.93) % | ||||
Operating Margin | (0.71) % | ||||
Price To Sales | 0.66 X | ||||
Revenue | 22.6 M |
Streamline Health Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 31.7M | 26.0M | 61.8M | 61.5M | 41.7M | 32.0M | |
Other Current Liab | 2.5M | 1.5M | 6.0M | 6.7M | 3.6M | 2.8M | |
Net Debt | 2.2M | 312K | 256K | 3.2M | 7.4M | 7.7M | |
Retained Earnings | (79.4M) | (79.1M) | (85.7M) | (97.0M) | (115.7M) | (109.9M) | |
Accounts Payable | 1.3M | 272K | 778K | 626K | 1.3M | 1.1M | |
Net Receivables | 4.0M | 3.1M | 4.7M | 8.7M | 5.0M | 5.1M | |
Other Current Assets | 919K | 1.8M | 568K | 710K | 629K | 1.2M | |
Total Liab | 15.6M | 8.5M | 27.8M | 26.0M | 22.9M | 16.6M | |
Total Current Assets | 6.6M | 7.3M | 15.1M | 16.0M | 8.8M | 12.7M | |
Short Term Debt | 3.8M | 1.7M | 454K | 785K | 1.5M | 1.2M | |
Cash | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.6M | |
Other Liab | 55K | 130K | 4.6M | 271K | 311.7K | 296.1K | |
Other Assets | 695K | 886K | 948K | 1.7M | 1.5M | 1.0M | |
Common Stock | 305K | 316K | 478K | 576K | 590K | 619.5K | |
Intangible Assets | 8.7M | 6.6M | 22.3M | 20.6M | 17.9M | 13.0M | |
Inventory | 1.3M | 901K | 1.4M | 1.0 | 0.9 | 0.86 | |
Net Tangible Assets | (8.2M) | 208K | (11.4M) | (2.4M) | (2.7M) | (2.9M) | |
Long Term Debt Total | 3.9M | 3.4M | 989K | 9.0M | 8.1M | 5.4M | |
Capital Surpluse | 82.5M | 95.1M | 96.3M | 132.0M | 151.8M | 89.1M |
Streamline Health Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Revenue | 20.7M | 11.3M | 17.4M | 24.9M | 22.6M | 19.1M | |
Gross Profit | 13.3M | 5.7M | 8.8M | 11.5M | 11.5M | 9.9M | |
Operating Income | (1.5M) | (5.8M) | (10.8M) | (10.8M) | (19.6M) | (18.7M) | |
Ebit | (1.5M) | (7.4M) | (6.6M) | (11.1M) | (17.7M) | (16.8M) | |
Ebitda | 628K | (4.8M) | (2.9M) | (6.2M) | (12.8M) | (12.2M) | |
Cost Of Revenue | 7.5M | 5.7M | 8.6M | 13.4M | 11.1M | 9.2M | |
Net Income | (2.9M) | (4.8M) | (6.9M) | (11.4M) | (18.7M) | (17.8M) | |
Income Tax Expense | 22K | (1.3M) | 109K | 71K | (46K) | (48.3K) | |
Interest Expense | 309K | 51K | 236K | 749K | 1.1M | 1.0M | |
Research Development | 3.6M | 2.9M | 4.8M | 6.0M | 8.2M | 4.3M | |
Income Before Tax | (2.8M) | (6.1M) | (6.8M) | (11.3M) | (18.7M) | (17.8M) | |
Tax Provision | 22K | (1.3M) | 109K | 71K | (46K) | (48.3K) | |
Net Interest Income | (309K) | (51K) | (236K) | (749K) | (1.1M) | (1.0M) |
Streamline Health Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (727K) | 760K | 7.5M | (3.3M) | (3.4M) | (3.2M) | |
Free Cash Flow | (3.4M) | (7.6M) | (5.0M) | (9.1M) | (3.8M) | (3.6M) | |
Depreciation | 2.1M | 2.2M | 3.2M | 4.3M | 4.3M | 2.8M | |
Capital Expenditures | 3.4M | 1.8M | 1.5M | 1.9M | 1.6M | 2.1M | |
Net Income | (2.9M) | (4.8M) | (6.9M) | (11.4M) | (18.7M) | (17.8M) | |
End Period Cash Flow | 1.6M | 2.4M | 9.9M | 6.6M | 3.2M | 5.5M | |
Other Non Cash Items | 544K | (1.8M) | (3.2M) | 118K | 8.8M | 9.3M | |
Change To Inventory | (13M) | 201M | 31M | 129K | 148.4K | 155.8K | |
Net Borrowings | (4.4M) | (1.7M) | 10M | (270K) | (243K) | (230.9K) | |
Change To Netincome | 947K | (830K) | (1.8M) | 1.9M | 1.7M | 1.8M | |
Investments | (3.4M) | 9.5M | (13.2M) | (1.9M) | (1.6M) | (1.7M) |
Streamline Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Streamline Health's current stock value. Our valuation model uses many indicators to compare Streamline Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Streamline Health competition to find correlations between indicators driving Streamline Health's intrinsic value. More Info.Streamline Health Solutions is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Streamline Health's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Streamline Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Streamline Health Systematic Risk
Streamline Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Streamline Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Streamline Health correlated with the market. If Beta is less than 0 Streamline Health generally moves in the opposite direction as compared to the market. If Streamline Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Streamline Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Streamline Health is generally in the same direction as the market. If Beta > 1 Streamline Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Streamline Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Streamline Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Streamline Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Streamline Health November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Streamline Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Streamline Health Solutions. We use our internally-developed statistical techniques to arrive at the intrinsic value of Streamline Health Solutions based on widely used predictive technical indicators. In general, we focus on analyzing Streamline Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Streamline Health's daily price indicators and compare them against related drivers.
Information Ratio | (0.09) | |||
Maximum Drawdown | 55.52 | |||
Value At Risk | (14.33) | |||
Potential Upside | 19.4 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (4.80) | Revenue Per Share 5.249 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.